NCT02183441View on ClinicalTrials.gov

Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

BI 1356

DRUG

Ritonavir

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY